Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.
Recursion Pharmaceuticals has raised $200.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2024.
Recursion Pharmaceuticals's investors include NVIDIA, Menlo Ventures, Lux Capital, Felicis, Obvious Ventures.
Recursion Pharmaceuticals is headquartered in Salt Lake City, United States.
Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.
Recursion Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Recursion Pharmaceuticals — Funding & Investors." VCBacked, June 26, 2024, https://www.vcbacked.co/company/recursion-pharmaceuticals. Accessed July 19, 2026.
VCBacked. (2024). Recursion Pharmaceuticals — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/recursion-pharmaceuticals
{{cite web |title=Recursion Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/recursion-pharmaceuticals |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated